Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dysthyroid Orbitopathy”

201 trials

Showing 20 of 201 results

Testing effectiveness (Phase 2)UnknownNCT02373995
What this trial is testing

Role of the Microbiome in Graves' Orbitopathy

Who this might be right for
Graves' Disease
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 60
Very early researchUnknownNCT05532072
What this trial is testing

Rapamycin Plus Methylprednisolone Versus Methylprednisolone Alone in Active, Moderate-to-severe Graves' Orbitopathy.

Who this might be right for
Graves Ophthalmopathy
First Affiliated Hospital Xi'an Jiaotong University 140
Testing effectiveness (Phase 2)Study completedNCT00150111
What this trial is testing

Rituximab in the Treatment of Graves' Disease

Who this might be right for
Graves´ DiseaseThyroid Associated Ophthalmopathy
Odense University Hospital 20
Large-scale testing (Phase 3)Study completedNCT05176639
What this trial is testing

A Safety, Tolerability, and Efficacy Study of Veligrotug (VRDN 001) in Participants With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 113
Post-approval studies (Phase 4)Looking for participantsNCT06927375
What this trial is testing

A Study on the Combined Use of Tocilizumab and Flupentixol-Melitracen in the Treatment of Thyroid-Associated Ophthalmopathy

Who this might be right for
Thyroid-Associated Ophthalmopathy
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 60
Early research (Phase 1)Study completedNCT06563856
What this trial is testing

TEPEZZA Subcutaneous Administration in Healthy Adults

Who this might be right for
BioavailabilityBioequivalence
Amgen 37
Large-scale testing (Phase 3)Study completedNCT06021054
What this trial is testing

An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 188
Not applicableStudy completedNCT05731154
What this trial is testing

Development of an AI Solution to Evaluate Clinical Activity of TAO Using Periocular Images Taken by Smartphones in Patients With Thyroid Dysfunction

Who this might be right for
Thyroid Eye Disease
Seoul National University Bundang Hospital 100
Not applicableStudy completedNCT01408368
What this trial is testing

Subtotal Versus Total Thyroidectomy for Graves' Disease

Who this might be right for
ThyroidGoiter
Jagiellonian University 200
Post-approval studies (Phase 4)Study completedNCT04583735
What this trial is testing

A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease

Who this might be right for
Thyroid Eye DiseaseChronic (Inactive) Thyroid Eye Disease
Amgen 62
Large-scale testing (Phase 3)Study completedNCT00595335
What this trial is testing

Trial of Rituximab for Graves' Ophthalmopathy

Who this might be right for
Thyroid-associated Ophthalmopathy
Rebecca Bahn 25
Not applicableEnded earlyNCT02316691
What this trial is testing

B-cell Depletion Therapy With Rituximab for Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
University of Pittsburgh 2
Large-scale testing (Phase 3)Looking for participantsNCT06989918
What this trial is testing

MHB018A Treatment in Patients With Active Thyroid Eye Disease

Who this might be right for
Thyroid Associated Ophthalmopathies
Minghui Pharmaceutical (Hangzhou) Ltd 108
Not applicableUnknownNCT01280214
What this trial is testing

Local Triamcinolone Injection in Active Thyroid Orbitopathy

Who this might be right for
Thyroid Disease
HaEmek Medical Center, Israel 30
Not applicableLooking for participantsNCT07480720
What this trial is testing

Systemic Inflammation, Thyroid Autoimmunity and Neuroretinal Changes in Graves Disease

Who this might be right for
Graves DiseaseGraves Ophthalmopathy
Elazıg Fethi Sekin Sehir Hastanesi 100
Testing effectiveness (Phase 2)Study completedNCT04311606
What this trial is testing

Anti-VEGF Therapy for Acute Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Massachusetts Eye and Ear Infirmary 11
Post-approval studies (Phase 4)Study completedNCT01599273
What this trial is testing

Treatment of Upper Eyelid Retraction Related to Thyroid-associated Ophthalmopathy Using Subconjunctival Triamcinolone Injections

Who this might be right for
Thyroid-associated Ophthalmopathy
Yonsei University 50
Early research (Phase 1)Study completedNCT05776121
What this trial is testing

Study of ZB001 in Chinese Patients With Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Zenas BioPharma (USA), LLC 17
Post-approval studies (Phase 4)Study completedNCT01458600
What this trial is testing

Adjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study)

Who this might be right for
Graves´ Disease
Mikael Lantz 65
Not applicableStudy completedNCT07056114
What this trial is testing

Multi-modal Medical Images for Extraocular Muscle Fibrosis Assessment

Who this might be right for
Thyroid Eye Disease, TED
Tianjin Eye Hospital 58
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation